Omicron is the new Covid variant that is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms. (File)
Coronavirus Live Updates: Delhi Health Minister Satyendar Jain on Thursday said that four more cases of Omicron have been detected in the national, taking the total count to 10. The Minister said there are currently 40 people, who are suspected cases of the variant, admitted to Lok Nayak Hospital, of whom 38 are Covid-19 positive. He added that eight of these were referred to the hospital from IGI airport on Thursday morning. “None of the cases have displayed any severe symptoms till now,” Jain said.
On Wednesday, West Bengal and Tamil Nadu reported their first Omicron cases. In Bengal, a seven-year-old boy tested positive for the new coronavirus variant, after returning from Abu Dhabi via Hyderabad. In Tamil Nadu, a 47-year-old who had arrived from Nigeria was found to be infected with Omicron. Samples of six of his family members who had also tested positive for Covid-19 have been sent for genome sequencing.
Meanwhile, India on Thursday recorded 7,974 Covid-19 cases and 343 deaths. With 7,948 recoveries, the active cases in the country stood at 87,245.
Live Blog
Omicron Coronavirus India LIVE: India records 7,974 Covid-19 cases; Tamil Nadu, West Bengal report first Omicron cases; Follow live updates here.
Covid shot for kids above 3 years will be ready in 6 months: Adar Poonawalla
With the opening of schools across the country underscoring the need for the Covid vaccination drive to cover children, Covishield manufacturer Serum Institute of India’s CEO Adar Poonawalla said Tuesday that SII is planning to launch a vaccine for those below the age of 18 “all the way down to the age of three” within the next six months.
[youtube https://www.youtube.com/watch?v=Cvic6EUBQ-w]
Speaking at the 27th CII Partnership Summit 2021 during a virtual conference, Poonawalla said the vaccine, Covovax, is under trial.
“We are going to be launching a vaccine in six months for children all the way down to the age of three… At the moment, Covishield is not recommended or approved in people below the age of 18 so that’s why Covovax is under trials and has shown excellent data all the way down to the age group of 3,” he said.
Omicron is the new Covid variant that is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms. (File)Coronavirus Live Updates: Delhi Health Minister Satyendar Jain on Thursday said that four more cases of Omicron have been detected in the national, taking the total count to 10. The Minister said there are currently 40 people, who are suspected cases of the variant, admitted to Lok Nayak Hospital, of whom 38 are Covid-19 positive. He added that eight of these were referred to the hospital from IGI airport on Thursday morning. “None of the cases have displayed any severe symptoms till now,” Jain said. On Wednesday, West Bengal and Tamil Nadu reported their first Omicron cases. In Bengal, a seven-year-old boy tested positive for the new coronavirus variant, after returning from Abu Dhabi via Hyderabad. In Tamil Nadu, a 47-year-old who had arrived from Nigeria was found to be infected with Omicron. Samples of six of his family members who had also tested positive for Covid-19 have been sent for genome sequencing. Meanwhile, India on Thursday recorded 7,974 Covid-19 cases and 343 deaths. With 7,948 recoveries, the active cases in the country stood at 87,245. Live BlogOmicron Coronavirus India LIVE: India records 7,974 Covid-19 cases; Tamil Nadu, West Bengal report first Omicron cases; Follow live updates here.Covid shot for kids above 3 years will be ready in 6 months: Adar Poonawalla With the opening of schools across the country underscoring the need for the Covid vaccination drive to cover children, Covishield manufacturer Serum Institute of India’s CEO Adar Poonawalla said Tuesday that SII is planning to launch a vaccine for those below the age of 18 “all the way down to the age of three” within the next six months. [youtube https://www.youtube.com/watch?v=Cvic6EUBQ-w] Speaking at the 27th CII Partnership Summit 2021 during a virtual conference, Poonawalla said the vaccine, Covovax, is under trial. “We are going to be launching a vaccine in six months for children all the way down to the age of three… At the moment, Covishield is not recommended or approved in people below the age of 18 so that’s why Covovax is under trials and has shown excellent data all the way down to the age group of 3,” he said.